Associate Professor Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She has worked predominantly on large-scale prospective studies such as EPIC and the Million Women Study and has a keen research interest in the role of diet, hormones and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world. In 2011, she became Senior Epidemiologist for UK Biobank and helps co-ordinate record linkage of routine health-related datasets into the study.
High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC. et al, (2019), Cancer Res
C-reactive protein and ovarian cancer risk: Results from the Ovarian Cancer Cohort Consortium
ALLEN N., (2019), Cancer Research
The advantages of UK Biobank's open access strategy for health research.
Conroy M. et al, (2019), J Intern Med
Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data.
Wilkinson T. et al, (2019), Eur J Epidemiol, 34, 557 - 565
Body Fat Distribution and Systolic Blood Pressure in 10,000 Adults with Whole-Body Imaging: UK Biobank and Oxford BioBank.
Malden D. et al, (2019), Obesity (Silver Spring)